Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Matinas BioPharma Holdings Inc buy DomRuinart

Start price
€0.93
06.04.21 / 50%
Target price
€2.00
06.04.22
Performance (%)
-25.41%
End price
€0.69
19.04.21
Summary
This prediction ended on 19.04.21 with a price of €0.69. The price of Matinas BioPharma Holdings Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.41%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Matinas BioPharma Holdings Inc 3.235% 3.235% -51.210% -77.471%
iShares Core DAX® 1.395% -0.272% 17.642% 15.576%
iShares Nasdaq 100 2.287% 6.912% 37.651% 51.525%
iShares Nikkei 225® 1.617% 3.038% 12.910% 8.243%
iShares S&P 500 0.659% 3.687% 29.434% 44.236%

According to DomRuinart what are the pros and cons of Matinas BioPharma Holdings Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Matinas BioPharma Holdings Inc diskutieren
Prediction Buy
Perf. (%) -25.41%
Target price 2.000
Change
Ends at 06.04.22

Buy mit Kursziel 2,0

In the thread Trading Matinas BioPharma Holdings Inc
Prediction Buy
Perf. (%) -25.41%
Target price 2.000
Change
Ends at 06.04.22

Buy beendet